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Abstract
Aim: A new technique allowing placement of umbilical silicone venous catheters (USVC) is described
and compared with percutaneous silicone venous catheters (PSVC).
Methods: Data were retrospectively recorded for 198 infants with USVC and 141 infants with PSVC.
Results: Overall rate of complications was low and comparable in both groups: thrombosis 1.2%,
catheter-related sepsis 3.5% and mechanical obstruction 5%.
Conclusion: A new device allows safe introduction of silicone catheters into the umbilical vein.
The percutaneous silicone venous catheter (PSVC) is the
preferred small-diameter central venous access in preterm
infants (1). The umbilical vein is also a commonly used and
easily accessible central venous route. However, because of
a significant incidence of thrombosis, the polyurethane or
polyvinyl chloride umbilical catheters are not suitable for
long-termuse(2,3).Siliconecatheterslackstiffnessfordirect
umbilical insertion. Therefore, we designed a new device for
the introduction of the silicone catheter into the umbilical
vein. The concept is shown in Figure 1 (ref.2184.01, Vygon).
A rigid introducer serves as guide for advancing the silicone
catheter into the umbilical vein. The umbilical silicone ve-
nous catheter (USVC) is inserted under classical conditions
of sterile umbilical catheterisation. The silicone catheter and
theeasy-lockconnectionsystemareflushedwithsaline.One
of the three introducers is chosen according to the required
catheter insertion distance and flushed with saline too. The
silicone catheter is inserted and pushed forward into the in-
troducer 1–2 mm ahead of its distal end. A haemostat for-
ceps is gently clamped at the proximal end of the introducer
and will stop the catheter from moving. The introducer with
the silicone catheter in his lumen is now inserted and ad-
vanced into the umbilical vein. The haemostat forceps is
removed. After the introducer is advanced the appropriate
distance, the silicone catheter is disconnected from the easy-
lock infusion system. The introducer is carefully withdrawn
and the catheter maintained in place by pushing it forward
with a nontoothed forceps, similar to the percutaneous in-
sertion. The silicone catheter is connected again with the
infusion system and the tip position adjusted if needed.
The position of the silicone catheter is verified by X-rays.
If the catheter tip is not in the correct position (i.e. in the
portal vein), it is promptly removed and the percutaneous
route is used.
The catheter position is documented again 1 or 2 days
later by echocardiography and eventually adjusted. Indeed,
X-rays alone can be misleading for evaluation of catheter
placement (4). Echocardiography is repeated 1 or 2 days
before removal to exclude thrombosis. The patients with
an umbilical line undergo abdominal echography before
discharge in order to verify the portal and deep venous
circulation.
All newborn infants admitted in the NICU of Saint-Pierre
University Hospital between January 2002 and December
2005 and who underwent central silicone catheterisation
were included in this study. Data on catheter complica-
tions were retrospectively abstracted from patient records.
The silicone catheters were preferentially inserted by umbil-
ical route during the first 2 days of life using the technique
described above. The percutaneous route was used if the
attending physician was not familiar with the USVC tech-
nique, if the umbilical vein was not accessible anymore or
if the USVC was incorrectly positioned ( i.e. portal vein).
The 339 patients were divided into four groups: those who
had one catheter, whether transumbilical (group USVC,
n = 161) or percutaneous (group PSVC, n = 125); those
who had more than one catheter, an USVC followed by one
or more PSVCs (group USVC–PSVC, n = 37) and those who
had several PSVCs (group PSVC–PSVC, n = 16).
We used  2 test or Fisher’s exact test to compare pro-
portions. For numerical variables with a Gaussian distribu-
tion, comparisons between groups were performed using the
Student’s t-test. For those with a non-Gaussian distribution
we used the Mann–Whitney U-test. For comparing rates of
catheter related sepsis per 1000 catheter days, we used exact
probabilities based on the binomial distributions.
Patients who underwent USVC placement had birth
weight ranging from 570 gm up to 3800 gm. Most of the
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Figure 1 The USVC introducers ( 8.9 and 11 cm), the silicone catheter and the easy-lock connection.
Table 1 Clinical characteristics and catheter use of study infants
One catheter Several catheters
USVC PSVC USVC + PSVC PSVC + PSVC
n = 161 n = 125 n = 37 n = 16
Median (min–max) or N◦ (%)
Birthweight (g) 1600 (700–3800) 1640 (760–3630) 1330 (570–2450) 1175 (740–3500)
Gestational age ( weeks) 32 (25–41) 32 (26–41) 29 (25–34) 28 (24–38)
Catheter inserted on ﬁrst day of life 132 (82.0%) 68 (54.4%)∗∗ 35 (94.6%) 13 (81.2%)
Number of catheters
2 – – 32 (86.5%) 14 (87.5%)
3–4 – – 5 (13.5%) 2 (12.5%)
Duration of catheterization (days)
Catheter 1 20 (2–48) 19 (3–62) 12 (1–43) 19 (1–42)
Catheter 2–4 – – 21 (5–77) 22 (4–54)
Elective withdrawal 156 (96.9%) 116 (92.8%) 21 (56.8%) 6 (37.5%)
∗∗p < 0.01 for comparison of PSVC (one catheter) with USVC (one catheter).
USVCs were placed at birth, significantly earlier than the
PSVCs (Table 1). A vast majority, 286 out of the 339 in-
fants had one central venous line lasting their whole hospital
stay. The frequencies of catheter complications are provided
stratified by catheter rank (Table 2). None of the classically
importantcathetercomplicationsweresignificantlydifferent
amonggroups.ThesmallgroupPSVC+PSVCshowedmore
mechanical obstruction (p < 0.01).
This study is the first evaluation of long-term transumbil-
ical venous access with silicone catheters in a large number
of patients. Former reports examined a very limited number
of cases and did not describe a specific device (5,6). This
study is neither prospective nor randomised but describes
a new technique that might have substantial advantages in
the intravascular access problems of newborn and especially
preterminfants.Ourdatademonstratethefeasibilitytoplace
USVC in all ranges of birth weight.
Thrombosis occurred in four of the patients of the USVC
group and not in the PSVC group. In 3 patients the routine
echocardiography showed small asymptomatic thrombi at
the catheter tip. They disappeared after thrombolytic treat-
ment. One severe growth retarded patient showed partial
portal vein thrombosis and portal hypertension diagnosed at
the age of 3 months on abdominal echography. The patient
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Table 2 Catheter complications
One catheter Several catheters
USVC PSVC USVC + PSVC PSVC + PSVC
n = 161 n = 125 n = 37 n = 16
N◦ (%) or rate per 1000 catheter days
Thrombosis
First catheter 3 (1.9%) 0 (0.0%) 1 (2.7%) 0 (0.0%)
Next catheter(s) – – 0 (0.0%) 0 (0.0%)
Mechanical obstruction
First catheter 0 (0.0%) 1 (0.8%) 6 (16.2%) 9 (56.3%)∗∗
Next catheter(s) – – 3 (8.1%) 0 (0.0%)
Catheter-related sepsis
First catheter 1 (0.6%) 3 (2.4%) 4 (10.8%) 2 (12.5%)
Per 1000 catheter days 0.31 1.16 7.60 6.99
Next catheter(s) – – 0 (0.0%) 2 (12.5%)
Per 1000 catheter days – – 0.00 5.09
Probably related catheter sepsis
First catheter 1 (0.6%) 5 (4.0%) 7 (18.9%) 0 (0.0%)
Per 1000 catheter days 0.31 1.94 13.31 0.00
Next catheter(s) – – 2 (5.4%) 0 (0.0%)
Per 1000 catheter days – – 2.13 0.00
∗∗p < 0.01 for comparison of PSVC + PSVC with USVC + PSVC.
completely recovered in follow-up. In our unit no heparin
is routinely used for catheter maintenance. In a recent ran-
domised controlled trial Shah et al. have shown that heparin
infusion prolonged the duration of the peripherally inserted
central venous catheter usability (7). This should be evalu-
ated in the USVCs in further studies. No severe side effect
like pericardial effusion or tamponade was observed in our
series. Risk of malposition of the USVC in the portal vein is
comparable to any venous umbilical catheterisation. Com-
parative data of venous catheters in published studies report
absence of complications in 51% to 82% of the patients (2,8–
12). In this study we observed no complications in 88% of
the patients.
In conclusion, we described the transumbilical use of a
small-diameter silicone venous catheter. A specific intro-
ducer is needed to achieve placement. Indications for USVC
placement are similar to PSVC. Complications in this study
are comparable for USVC and PSVC. The advantages of
USVC are an easy venous access, a sparing effect on pe-
ripheral veins and the baby’s comfort. Further studies are
needed to evaluate the use of USVC.
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